Eydelman Mikhail

SVP, Gen Counsel &Corp Sec | SVP, Gen Counsel &Corp Sec

1 company

Strong

Trades Analyzed

12M Win Rate

72.2%

Avg 3M Return

+3.9%

Avg 12M Return

+26.0%

Eydelman Mikhail is a SVP, Gen Counsel &Corp Sec at Vaxcyte, Inc.. Recent SEC Form 4 filings include 0 buys and 37 sells.

Estimated insider holdings value: $2.1M based on current market prices.

Holdings by Company

PCVXMar 5, 2025

Current Shares41.7K

Value$2.15M

Net Activity-80,503

Bought: 0Sold: 80.5K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 5, 2025	PCVX Vaxcyte, Inc.	SVP, Gen Counsel &Corp Sec	Sale+OE	5,000	$70.74	$353,699.01	-3.8%	-53.1%	-21.3%
Feb 5, 2025	PCVX Vaxcyte, Inc.	SVP, Gen Counsel &Corp Sec	Sale+OE	5,000	$90.07	$450,368.64	-3.2%	-67.3%	-39.7%
Jan 6, 2025	PCVX Vaxcyte, Inc.	SVP, Gen Counsel &Corp Sec	Sale+OE	5,000	$85.58	$427,922.80	-5.3%	-62.2%	-47.8%
Dec 5, 2024	PCVX Vaxcyte, Inc.	SVP, Gen Counsel &Corp Sec	Sale+OE	5,000	$91.49	$457,433.92	-5.3%	-17.9%	-48.4%
Nov 5, 2024	PCVX Vaxcyte, Inc.	SVP, Gen Counsel &Corp Sec	Sale+OE	5,000	$106.36	$531,803.36	-3.9%	-21.2%	-62.5%
Oct 7, 2024	PCVX Vaxcyte, Inc.	SVP, Gen Counsel &Corp Sec	Sale+OE	5,000	$109.27	$546,352.55	-3.2%	-20.7%	-61.4%
Oct 1, 2024	PCVX Vaxcyte, Inc.	SVP, Gen Counsel &Corp Sec	Sale+OE	5,500	$114.24	$628,294.76	-5.7%	-29.0%	-67.1%
Sep 3, 2024	PCVX Vaxcyte, Inc.	SVP, Gen Counsel &Corp Sec	Sale+OE	1,667	$112.11	$186,879.52	-0.8%	-16.8%	-70.9%
Aug 1, 2024	PCVX Vaxcyte, Inc.	SVP, Gen Counsel &Corp Sec	Sale+OE	1,667	$78.85	$131,449.20	-2.6%	+35.0%	-58.0%
Jul 1, 2024	PCVX Vaxcyte, Inc.	SVP, Gen Counsel &Corp Sec	Sale+OE	1,667	$76.37	$127,303.98	-2.6%	+48.5%	-57.2%